Fig. 9From: Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trialsForest plot of meta-analysis for the comparison of infection adverse events between the SGLT-2i and placebo groups. a Urinary tract infection adverse outcomes, b male genital infection adverse outcomes, c female genital infection adverse outcomesBack to article page